Kang M - Search Results

1

Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma.

Li Z, Li C, Yang D, Zhou Z, Kang M. Li Z, et al. Among authors: kang m. Biomed Res Int. 2023 Jan 17;2023:7126881. doi: 10.1155/2023/7126881. eCollection 2023. Biomed Res Int. 2023. PMID: 36704722 Free PMC article.

2

Long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treatment of nasopharyngeal carcinoma with cervical lymph node metastases.

Kang M, Liu WQ, Qin YT, Wei ZX, Wang RS. Kang M, et al. Asian Pac J Cancer Prev. 2013;14(12):7395-400. doi: 10.7314/apjcp.2013.14.12.7395. Asian Pac J Cancer Prev. 2013. PMID: 24460309 Free article. Clinical Trial.

3

Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene.

Ou H, Li Y, Kang M. Ou H, et al. Among authors: kang m. PLoS One. 2014 Nov 3;9(11):e109929. doi: 10.1371/journal.pone.0109929. eCollection 2014. PLoS One. 2014. PMID: 25365510 Free PMC article.

4

Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.

Wang J, Kang M, Qin YT, Wei ZX, Xiao JJ, Wang RS. Wang J, et al. Among authors: kang m. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6936-43. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261581 Free PMC article.

5

A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.

Kang M, Long J, Li G, Yan H, Feng G, Liu M, Zhu J, Wang R. Kang M, et al. Oncotarget. 2016 Mar 22;7(12):15252-61. doi: 10.18632/oncotarget.7553. Oncotarget. 2016. PMID: 26918446 Free PMC article.

6

MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1.

Kang M, Xiao J, Wang J, Zhou P, Wei T, Zhao T, Wang R. Kang M, et al. Cancer Med. 2016 Jun;5(6):1163-73. doi: 10.1002/cam4.660. Epub 2016 Feb 29. Cancer Med. 2016. PMID: 26922862 Free PMC article.

7

Triptolide Combined with Radiotherapy for the Treatment of Nasopharyngeal Carcinoma via NF-κB-Related Mechanism.

Zhang W, Kang M, Zhang T, Li B, Liao X, Wang R. Zhang W, et al. Among authors: kang m. Int J Mol Sci. 2016 Dec 19;17(12):2139. doi: 10.3390/ijms17122139. Int J Mol Sci. 2016. PMID: 27999372 Free PMC article.

8

Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.

Kang M, Zhou P, Liao X, Xu M, Wang R. Kang M, et al. Oral Oncol. 2017 Dec;75:100-105. doi: 10.1016/j.oraloncology.2017.11.002. Epub 2017 Nov 10. Oral Oncol. 2017. PMID: 29224805

9

Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma.

Kang M, Wang F, Liao X, Zhou P, Wang R. Kang M, et al. Medicine (Baltimore). 2018 Jun;97(25):e11118. doi: 10.1097/MD.0000000000011118. Medicine (Baltimore). 2018. PMID: 29924009 Free PMC article. Clinical Trial.

10

Bioinformatics analysis identifies hub genes and pathways in nasopharyngeal carcinoma.

Liu K, Kang M, Zhou Z, Qin W, Wang R. Liu K, et al. Among authors: kang m. Oncol Lett. 2019 Oct;18(4):3637-3645. doi: 10.3892/ol.2019.10707. Epub 2019 Aug 2. Oncol Lett. 2019. PMID: 31516577 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,437 results

Search Page

Filters